<?xml version="1.0" encoding="UTF-8"?>
<p id="Par24">
 <italic>Dried Blood Spot (DBS)</italic> were also collected and analyzed at the central laboratory of the National Institute of Health. Central-level HBV tests were performed at the National Institute of Health Laboratory using ELISA MurexÂ® HBsAg Version 3 (Murex Biotech Limited, UK) and were used to estimate HBV prevalence in the survey; centralized HCV testing was not performed because a serologic anti-HCV assay using DBS had not been validated by the National Reference Laboratory at the time of the survey [
 <xref ref-type="bibr" rid="CR6">6</xref>, 
 <xref ref-type="bibr" rid="CR7">7</xref>].
</p>
